ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 173

Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Readmission Rates in Henoch-Schönlein Purpura with Gastrointestinal Involvement

Maria Pereira1, Miriah Gillispie-Taylor 2, Pooja Patel 3, Michael Nelson 4, Ugo Awa 4, Monica Bray 5, Amanda Brown 4, Andrea Ramirez 6, MaiLan Nguyen 4, Saimun Singla 4, Tiphanie Vogel 4, Eyal Muscal 5, Marietta De Guzman 6, Elisabeth Hastings 7, Ashleigh Russell 7 and Kristina Lakenmacher 7, 1Assistant Professor, Section of Rheumatology, Division of Pediatrics, Baylor College of Medicine, Houston, Texas, 2Levine Children's Hospital, Charlotte, 3Baylor College of Medicine, Houston, Texas, 4Baylor College of Medicine, Houston, 5Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, 6Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, 7Texas Children's Hospital, Houston

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Henoch-Schönlein purpura, nutrition, quality improvement

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Henoch-Schönlein Purpura (HScP) is the most common form of vasculitis in children, with gastrointestinal (GI) complaints occurring in more than a third of patients within one week of symptom onset. Patients may require hospitalization for pain control, intravenous hydration, bowel rest and parenteral nutrition, and disease monitoring for intestinal intussusception and bowel perforation. Reintroducing enteral nutrition during the period of active intestinal vasculitis can be challenging and may result in recurrence of abdominal symptoms and lead to readmission. No established pediatric dietary recommendations exist for HScP. We sought to improve non pharmacologic management by implementing a quality improvement initiative with the goal of reducing 30-day readmission rates by half in the first 12 months of intervention. Our aim was to provide diet recommendation to all patients admitted with HScP with a pediatric rheumatology consult.

Methods: We retrospectively reviewed the medical records of 20 HScP patients with GI involvement who were admitted in 2015 to determine that the 30-day readmission rate was 50%. Review of inpatient management had been similar with inclusion of glucocorticoids, bowel rest for severe involvement, and optimal fluid and electrolyte therapy. There was, however, variability in the dietary management of these patients. Specific diet recommendations were created by a group of hospital dietitians and pediatric rheumatologists. These recommendations were based on providers’ own observations combined with knowledge about diets low in acid, complex carbohydrates, and fats that are predicted to result in less gastrointestinal distress and better absorption. We also took into consideration dietary modifications recommended for patients with inflammatory bowel disease. Three HScP diet stages were created to facilitate diet advancement and were instituted using specific comments in the electronic diet orders. Smart phrases were created for the consistency of the dietary advice. All patients were seen by dietitian for patient and parental education.

Results: A total of 36 patients at Texas Children’s Hospital had a pediatric rheumatology consult for management of HScP with GI involvement between 2017 to 2019. We found that the 30-day readmission rate was reduced to 25% in 2017, 17% in 2018, and 25% in 2019. Our goal was achieved in the first 12 months with similar outcomes in the subsequent 24 months of the diet implementation. All rheumatology attendings and fellows adhered to dietary intervention as part of initial and follow up consult recommendations.

Conclusion: Our dietary intervention showed a reduction in the 30-day readmission rates. Due to lack of evidence, the creation of the HScP diet required collaboration across dietitians, rheumatologist, patients, families, and food service. Future directions include additional modifications to the diet to increase patient compliance, simplify electronic diet orders, and continue education among dietitians and pediatric hospital providers. Our ultimate goal is to design a hospital admission order set with best practice alerts to standardize the dietary intervention.


Disclosure: M. Pereira, None; M. Gillispie-Taylor, None; P. Patel, None; M. Nelson, None; U. Awa, None; M. Bray, None; A. Brown, None; A. Ramirez, None; M. Nguyen, None; S. Singla, None; T. Vogel, None; E. Muscal, None; M. De Guzman, None; E. Hastings, None; A. Russell, None; K. Lakenmacher, None.

To cite this abstract in AMA style:

Pereira M, Gillispie-Taylor M, Patel P, Nelson M, Awa U, Bray M, Brown A, Ramirez A, Nguyen M, Singla S, Vogel T, Muscal E, De Guzman M, Hastings E, Russell A, Lakenmacher K. Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Readmission Rates in Henoch-Schönlein Purpura with Gastrointestinal Involvement [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/impact-of-a-nutrition-focused-quality-improvement-intervention-on-hospital-readmission-rates-in-henoch-schonlein-purpura-with-gastrointestinal-involvement/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-a-nutrition-focused-quality-improvement-intervention-on-hospital-readmission-rates-in-henoch-schonlein-purpura-with-gastrointestinal-involvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology